Region: Global
Category: Drug Discovery

Global Drug Discovery

(1,902 reports matching your criteria)
  • Global Dementia and Movement Disorder Treatment Market 2025-2029

    ... report on the dementia and movement disorder treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an ... Read More

  • Global Antipsychotic Drugs Market - 2025-2033

    ... during the forecast period 2025-2033. Antipsychotic drugs, commonly known as painkillers, are a class of drugs designed to relieve pain. They work by blocking pain signals in the body or by altering the way the ... Read More

  • Global Focal Segmental Glomerulosclerosis Drugs Market - 2025-2033

    ... of 15.7% during the forecast period of 2025-2033. Focal segmental glomerulosclerosis (FSGS) is a kidney disorder marked by scarring in parts of the glomeruli, the filtering units of the kidney. The disease can arise from ... Read More

  • Global Musculoskeletal Diseases Treatment Market - 2025-2033

    ... period 2025-2033. Musculoskeletal Diseases Treatment Market The musculoskeletal diseases treatment market is a rapidly evolving sector of the global healthcare industry, addressing a wide spectrum of disorders that affect the body's bones, muscles, joints, ligaments, ... Read More

  • Global Binge-eating Disorder Treatment Market 2025-2029

    ... disorder treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market ... Read More

  • Global Infantile Spasms Therapeutics Market 2025-2029

    ... spasms therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market ... Read More

  • Global Behcets Disease Therapeutics Market 2025-2029

    ... disease therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market ... Read More

  • Global & Vietnam Cancer Therapeutics Market to 2031

    ... access to cancer care services. The Vietnamese Ministry of Health has teamed up with global pharma companies to increase the availability of oncology drugs within public healthcare facilities. These efforts have helped bring innovative cancer ... Read More

  • Oligonucleotide Synthesis Market by Product ((Drugs (ASO, siRNA), Synthesized Oligos (Product (Primers, Probes)), Type ((Custom, Predesigned), Reagents, Equipment), Application (Therapeutic (Rare Diseases), Research, Diagnostics) - Global Forecast to 2030

    ... by several factors, such as the increasing demand for synthesized oligonucleotides like primers & probes for several research & diagnostic applications. Rising technological advancements in oligonucleotide synthesis are also expected to contribute to market growth ... Read More

  • Global & Greece Cancer Therapeutics Market to 2031

    ... reported in 2022, with the disease causing more than 32,000 deaths. Among men, prostate, lung, and colorectal cancers are the most commonly diagnosed, while breast cancer leads among women, followed by colorectal and lung cancers. ... Read More

  • Global & Finland Cancer Therapeutics Market to 2031

    ... men; colorectal cancer affected both genders significantly. This rising cancer incidence has driven increased demand for innovative and effective treatment options. Leading research institutions such as the University of Helsinki, the Finnish Institute for Molecular ... Read More

  • Global & Luxembourg Cancer Therapeutics Market to 2031

    ... all yearly fatalities in the country. Luxembourg has become a key player in global cancer research and oncology, demonstrated by its substantial investment in research infrastructure, international collaborations, and development of scientific expertise. The nation ... Read More

  • Global & Norway Cancer Therapeutics Market to 2031

    ... In 2023, the Norwegian Cancer Society allocated approximately US$ 6.67 million (NOK 71 million) to researchers at the Faculty of Medicine (MED), highlighting its commitment to advancing cancer research in the country. Further reinforcing these ... Read More

  • Global & South Korea Cancer Therapeutics Market to 2031

    ... approximately 274,488 new cancer cases that year. Thyroid cancer topped the list as the most frequently diagnosed, followed by lung, colorectal, breast, and stomach cancers. This growing cancer burden is fueling a corresponding surge in ... Read More

  • Global & Turkey Cancer Therapeutics Market to 2031

    ... including immunotherapy and targeted therapies. In response, the Turkish government has launched several initiatives to enhance the development and accessibility of such treatments. One key effort is the Ministry of Health's National Cancer Control Program, ... Read More

  • Global & New Zealand Cancer Therapeutics Market to 2031

    ... and death, with lung, breast, prostate, and colorectal cancers being the most prevalent. The incidence of cancer has steadily grown in recent years, driven by factors such as an aging population, lifestyle changes, and environmental ... Read More

  • Global & Argentina Cancer Therapeutics Market to 2031

    ... to The Global Cancer Observatory, Argentina recorded approximately 130,000 new cases and around 70,000 cancer-related deaths in 2020. The country sees high rates of cervical, colorectal, and breast cancers, with GLOBOCAN 2020 reporting nearly 15,895 ... Read More

  • Global & Algeria Cancer Therapeutics Market to 2031

    ... to treatment and improve patient outcomes by strengthening its healthcare infrastructure and introducing more advanced therapies. Acknowledging the urgency of addressing this public health challenge, the Algerian government—through the Ministry of Health—has implemented several measures ... Read More

  • Global & Bangladesh Cancer Therapeutics Market to 2031

    ... producing generic cancer medications, which helps make treatments more affordable and accessible to a larger segment of patients. However, the market faces challenges including the absence of widespread cancer screening programs, limited availability of advanced ... Read More

  • Global & Chile Cancer Therapeutics Market to 2031

    ... and Social Affairs reported that in 2019, around 11.5% of Chile's population was aged 65 or older, and this figure is projected to rise to 21% by 2041. Chile’s public health insurer, FONASA, currently provides ... Read More

  • Global & Colombia Cancer Therapeutics Market to 2031

    ... including chemotherapy and targeted therapies, to manage various cancer types such as breast cancer. In response, the Colombian government has implemented several measures to enhance cancer care and improve patient access to therapies. The National ... Read More

  • Global & Czech Republic Cancer Therapeutics Market to 2031

    ... contributing to this increase include high alcohol consumption and a growing obese population. The government plays a crucial role in cancer management through the maintenance of the National Oncological Register (NOR), which helps track and ... Read More

  • Global & France Cancer Therapeutics Market to 2031

    ... of individuals aged 85 and older is projected to increase by nearly 90% between 2030 and 2050. This growing elderly population is a significant factor contributing to the expansion of the cancer therapeutics market, as ... Read More

  • Global & Egypt Cancer Therapeutics Market to 2031

    ... of newly diagnosed cases continuing to climb. According to GLOBOCAN 2020 data, Egypt recorded approximately 134,632 new cancer cases and 89,042 deaths related to cancer that year. This growing health challenge has fueled demand for ... Read More

  • Global & Malaysia Cancer Therapeutics Market to 2031

    ... improve patient survival rates, the Ministry of Health established the National Cancer Control Blueprint. Data from the National Cancer Registry (NCR) indicates that approximately 50,000 new cancer cases are diagnosed annually in Malaysia, with breast, ... Read More

< prev 1 2 3 4 5 6 7 8 9 10

Research Assistance

Live help

Join Alert Me Now!

Sign Up

Find out more on our blog
Cookie Settings